Richardson Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.4K Sell
2,258
-10,176
-82% -$266K 0.03% 306
2026
Q1
$349K Buy
12,434
+1,105
+10% +$29.4K 0.22% 114
2025
Q4
$282K Buy
11,329
+6,377
+129% +$161K 0.09% 133
2025
Q3
$126K Buy
4,952
+190
+4% +$4.69K 0.08% 189
2025
Q2
$119K Buy
4,762
+605
+15% +$14.1K 0.08% 190
2025
Q1
$105K Buy
4,157
+290
+7% +$7.59K 0.08% 183
2024
Q4
$102K Sell
3,867
-8,253
-68% -$224K 0.07% 188
2024
Q3
$339K Hold
12,120
0.22% 113
2024
Q2
$339K Sell
12,120
-560
-4% -$15.4K 0.24% 107
2024
Q1
$352K Sell
12,680
-15,847
-56% -$440K 0.25% 102
2023
Q4
$821K Buy
+28,527
New +$862K 0.72% 39

Other funds holding PFE

Richardson Financial Services's PFE Position: Q2 2026 in Review

Richardson Financial Services reduced its Pfizer (PFE) stake by 82% in Q2 2026, selling an estimated $266K and leaving 2,258 shares worth $54.4K. The position accounts for 0.03% of the portfolio, ranked #306.

Richardson Financial Services first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $821K in Q4 2023. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Richardson Financial Services held 2,258 shares of Pfizer worth $54.4K as of Q2 2026.
  • Richardson Financial Services sold 10,176 Pfizer shares in Q2 2026, an estimated $266K.
  • Pfizer made up 0.03% of Richardson Financial Services's portfolio in Q2 2026, its #306 holding.
  • Richardson Financial Services first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Richardson Financial Services's Pfizer position peaked at $821K in Q4 2023.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.